Post-infection immune response in adults with COVID-19 with and without nirmatrelvir-ritonavir treatment and virologic rebound
Dibya Ghimire, Chloe M. Hasund, John Bianchi Colangeli…·Jacob E. Lemieux
This study examines immune responses in adults with COVID-19 who received or did not receive nirmatrelvir-ritonavir, finding no differences in immune markers between those with and without virologic rebound.